• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮中的恶性肿瘤:台湾的全国队列研究。

Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.

机构信息

Department of Dermatology, Taichung Veterans General Hospital, Taichung, Taiwan.

出版信息

Am J Med. 2010 Dec;123(12):1150.e1-6. doi: 10.1016/j.amjmed.2010.08.006.

DOI:10.1016/j.amjmed.2010.08.006
PMID:21183006
Abstract

BACKGROUND

an increased risk of malignancy in patients with systemic lupus erythematosus has been reported, but rarely in Asian populations. We aimed to investigate the relative risk of cancer and to identify the high-risk group for cancer in patients with lupus.

METHODS

we conducted a retrospective, nationwide cohort study that included 11,763 patients with lupus without a history of malignancies, using the national health insurance database of Taiwan from 1996 to 2007. Standardized incidence ratios (SIRs) of cancers were analyzed.

RESULTS

a total of 259 cancers were observed in patients with lupus. An elevated risk of cancer among those with systemic lupus erythematosus was noted (SIR 1.76; 95% confidence interval [CI] 1.74-1.79), especially for hematologic malignancies (SIR 4.96; 95% CI 4.79-5.14). Younger patients had a greater risk ratio of cancer than the general population, and the risk ratio decreased with age. The risk ratio of cancer decreased with time, yet remained elevated compared with that of the general population. The risk of non-Hodgkin lymphoma was greatest (SIR 7.27) among hematologic cancers. Among solid tumors, the risk was greatest for cancers of the vagina/vulva (SIR 4.76), nasopharynx (SIR 4.18), and kidney (SIR 3.99). An elevated risk for less common cancers, including those of the brain, oropharynx, and thyroid glands, was also observed.

CONCLUSION

patients with lupus are at increased risk of cancers and should receive age- and gender-appropriate malignancy evaluations, with additional assessment for vulva/vagina, kidney, nasopharynx, and hematologic malignancy. Continued vigilance for development of cancers in follow-up is recommended.

摘要

背景

系统性红斑狼疮患者的恶性肿瘤风险增加已有报道,但在亚洲人群中很少见。我们旨在调查癌症的相对风险,并确定狼疮患者的癌症高危人群。

方法

我们进行了一项回顾性、全国性队列研究,纳入了 1996 年至 2007 年期间来自台湾全民健康保险数据库的 11763 例无恶性肿瘤病史的狼疮患者。分析了癌症的标准化发病比(SIR)。

结果

共观察到 259 例狼疮患者发生癌症。系统性红斑狼疮患者的癌症风险升高(SIR 1.76;95%置信区间 [CI] 1.74-1.79),尤其是血液恶性肿瘤(SIR 4.96;95%CI 4.79-5.14)。年轻患者的癌症风险比高于普通人群,且随着年龄的增长风险比降低。癌症风险随时间下降,但仍高于普通人群。血液恶性肿瘤中,非霍奇金淋巴瘤的风险比最大(SIR 7.27)。在实体肿瘤中,阴道/外阴(SIR 4.76)、鼻咽(SIR 4.18)和肾脏(SIR 3.99)的癌症风险最大。还观察到一些罕见癌症(如脑、口咽和甲状腺)的风险增加。

结论

狼疮患者发生癌症的风险增加,应接受适合年龄和性别的恶性肿瘤评估,同时额外评估外阴/阴道、肾脏、鼻咽和血液恶性肿瘤。建议在随访中继续警惕癌症的发生。

相似文献

1
Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.系统性红斑狼疮中的恶性肿瘤:台湾的全国队列研究。
Am J Med. 2010 Dec;123(12):1150.e1-6. doi: 10.1016/j.amjmed.2010.08.006.
2
[The occurrence of malignancies in a Hungarian lupus population].[匈牙利狼疮患者群体中恶性肿瘤的发生情况]
Orv Hetil. 2006 Nov 19;147(46):2229-33.
3
Risk of malignancy in women with systemic lupus erythematosus.系统性红斑狼疮女性患者的恶性肿瘤风险。
J Rheumatol. 1995 Aug;22(8):1478-82.
4
The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.系统性红斑狼疮女性患者血液系统恶性肿瘤的年龄风险关系:一项全国性回顾性队列研究。
Lupus. 2012 Oct;21(11):1250-6. doi: 10.1177/0961203312451783. Epub 2012 Jun 27.
5
The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan.类风湿性关节炎患者的癌症风险:一项在台湾进行的全国性队列研究。
Arthritis Rheum. 2011 Feb;63(2):352-8. doi: 10.1002/art.30134.
6
An international cohort study of cancer in systemic lupus erythematosus.一项关于系统性红斑狼疮患者癌症的国际队列研究。
Arthritis Rheum. 2005 May;52(5):1481-90. doi: 10.1002/art.21029.
7
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.瑞士HIV队列研究中的癌症风险:与免疫缺陷、吸烟和高效抗逆转录病毒治疗的关联。
J Natl Cancer Inst. 2005 Mar 16;97(6):425-32. doi: 10.1093/jnci/dji072.
8
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.系统性红斑狼疮中癌症与药物暴露之间的关系:一项病例队列研究。
Ann Rheum Dis. 2008 Jan;67(1):74-9. doi: 10.1136/ard.2006.069039. Epub 2007 Jun 1.
9
Donation frequency, iron loss, and risk of cancer among blood donors.献血者的献血频率、铁流失与癌症风险
J Natl Cancer Inst. 2008 Apr 16;100(8):572-9. doi: 10.1093/jnci/djn084. Epub 2008 Apr 8.
10
Increased risk of malignancy in patients with systemic lupus erythematosus.系统性红斑狼疮患者患恶性肿瘤风险增加。
J Investig Med. 1998 Jun;46(5):217-22.

引用本文的文献

1
Cancer Risk in Autoimmune and Immune-Mediated Diseases: A Narrative Review for Practising Clinicians.自身免疫性和免疫介导性疾病中的癌症风险:面向临床医生的叙述性综述
J Clin Med. 2025 Aug 23;14(17):5954. doi: 10.3390/jcm14175954.
2
Evaluating the risk of digestive system cancer in autoimmune disease patients: a systematic review and meta-analysis focusing on bias assessment.评估自身免疫性疾病患者消化系统癌症的风险:一项侧重于偏倚评估的系统评价和荟萃分析
EClinicalMedicine. 2025 Aug 7;87:103410. doi: 10.1016/j.eclinm.2025.103410. eCollection 2025 Sep.
3
Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study.
韩国系统性红斑狼疮患者的癌症发病率及免疫抑制剂的影响:一项回顾性队列研究
Arthritis Res Ther. 2025 Jan 22;27(1):14. doi: 10.1186/s13075-025-03482-2.
4
Global research trends on systemic lupus erythematosus and thyroid cancers (1964-2023): A scientometric and visualized study.系统性红斑狼疮和甲状腺癌的全球研究趋势(1964-2023):一项科学计量学和可视化研究。
Medicine (Baltimore). 2024 Jun 28;103(26):e38511. doi: 10.1097/MD.0000000000038511.
5
The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren's syndrome, cancers, and cancer metabolism.TRIM21/Ro52在系统性红斑狼疮、原发性干燥综合征、癌症及癌症代谢中的相互关联作用。
Cancer Cell Int. 2023 Nov 22;23(1):289. doi: 10.1186/s12935-023-03143-x.
6
Epidemiology of systemic lupus erythematosus in Korea.韩国系统性红斑狼疮的流行病学
J Rheum Dis. 2023 Oct 1;30(4):211-219. doi: 10.4078/jrd.2023.0037. Epub 2023 Sep 11.
7
Systemic Inflammatory Disorders, Immunosuppressive Treatment and Increase Risk of Head and Neck Cancers-A Narrative Review of Potential Physiopathological and Biological Mechanisms.系统性炎症疾病、免疫抑制治疗与头颈部癌症风险增加:潜在病理生理学和生物学机制的综述。
Cells. 2023 Sep 1;12(17):2192. doi: 10.3390/cells12172192.
8
Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study.结缔组织病患者肺癌的临床特征与预后:一项回顾性队列研究
Front Oncol. 2023 Jun 5;13:1167213. doi: 10.3389/fonc.2023.1167213. eCollection 2023.
9
Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis.系统性红斑狼疮和前列腺癌风险:队列研究和孟德尔随机化分析的汇总。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9517-9528. doi: 10.1007/s00432-023-04853-5. Epub 2023 May 22.
10
Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival.新诊断的系统性红斑狼疮患者的恶性肿瘤及其生存情况。
Lupus. 2022 Dec;31(14):1750-1758. doi: 10.1177/09612033221131501. Epub 2022 Oct 6.